Guardant Health’s IPO Tops Range, Raising $238M for Cancer Tests | Enterpreneurship
Want create site? Find Free WordPress Themes and plugins.
Guardant Health continued the rapid drumbeat of life science IPOs this year by raising $237.5 million in its stock market debut, making it one of the biggest IPOs so far this year.
The cancer diagnostics company priced its offering of 12.5 million shares at $19 apiece late Wednesday, well above the $15 to $17 per share range it had targeted. Shares of the Redwood City, CA, company are expected to begin trading on the Nasdaq later today under the stock symbol “GH.”
According to IPO research firm Renaissance Capital, the third quarter saw 52 companies raise $11.2 billion in capital… Read more »
Reprints | Share: 
UNDERWRITERS AND PARTNERS
Did you find apk for android? You can find new Free Android Games and apps.